New Drug Shows Promise for Hard-to-Treat Ovarian Cancer
Researchers tested a new targeted cancer drug called mirvetuximab soravtansine (MIRV) on patients with ovarian cancer that had stopped responding to standard …
Read MoreAll content tagged with "chemotherapy alternatives"
Researchers tested a new targeted cancer drug called mirvetuximab soravtansine (MIRV) on patients with ovarian cancer that had stopped responding to standard …
Read MoreScientists have created tiny particles called nanoparticles designed to deliver cancer-fighting medicine directly to liver cancer cells while leaving healthy …
Read More